加载中
NYSEHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$15.06
+US$0.56 · +3.86%
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
前收盘价
US$15.06
+US$0.56 · +3.86%
盘中时间采用ET。市场数据可能有所延迟。
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
日内区间
当前US$15.06
52周区间
当前US$15.06
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
65
低估
情绪
56
多空交织
风险
58
风险偏高
动量
26
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
日内区间
当前US$15.06
52周区间
当前US$15.06
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$36.20
上涨空间 140.37%年度分割调整后的每股现金分配。
US$1.16
2025年（完整年度）+20.8% 自从 2021
2026年（部分年度）：US$0.87
US$0.96
2,021
US$1.04
2,022
US$1.092
2,023
US$1.104
2,024
US$1.16
2,025
US$0.87
2,026*
* 在现有股息历史记录中，该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月28日 | US$0.29Quarterly | 2026年8月28日 | 2026年9月15日 |
股息 | 2026年5月29日 | US$0.29Quarterly | 2026年5月29日 | 2026年6月16日 |
股息 | 2026年3月2日 | US$0.29Quarterly | 2026年3月2日 | 2026年3月24日 |
股息 | 2025年11月28日 | US$0.29Quarterly | 2025年11月28日 | 2025年12月16日 |
股息 | 2025年8月29日 | US$0.29Quarterly | 2025年8月29日 | 2025年9月16日 |
股息 | 2025年5月30日 | US$0.29Quarterly | 2025年5月30日 | 2025年6月17日 |
除息 2026年8月28日
US$0.29
Quarterly
2026年8月28日登记 · 支付日 2026年9月15日
除息 2026年5月29日
US$0.29
Quarterly
2026年5月29日登记 · 支付日 2026年6月16日
除息 2026年3月2日
US$0.29
Quarterly
2026年3月2日登记 · 支付日 2026年3月24日
除息 2025年11月28日
US$0.29
Quarterly
2025年11月28日登记 · 支付日 2025年12月16日
除息 2025年8月29日
US$0.29
Quarterly
2025年8月29日登记 · 支付日 2025年9月16日
除息 2025年5月30日
US$0.29
Quarterly
2025年5月30日登记 · 支付日 2025年6月17日
报告持有此股票敞口的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR1.2亿0.12%1031.91亿 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI6469.73万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM5373.58万0.07%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB4654.36万0.02%1853亿 USD0.03%US$289.48+0.64%
Invesco High Yield Equity Dividend Achievers ETFPEY4164.9万3.88%10.72亿 USD0.68%US$22.9364-0.67%
Vanguard Morningstar Small-Cap Value ETFVBR2960万0.04%682亿 USD0.05%US$234.43+0.22%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV2663.64万0.10%268.09亿 USD0.33%US$37.95-0.39%
Vanguard Extended Market ETFVXF2355.01万0.02%954亿 USD0.05%US$235+0.80%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBInvesco High Yield Equity Dividend Achievers ETFPEYVanguard Morningstar Small-Cap Value ETFVBRU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
